Christopher Haqq – Biography
Last update: 14 days agoExecutive profile
Christopher was Executive Vice President of Research and Development and Chief Scientific Officer for Atara Biotherapeutics.
Christopher Haqq is currentlyExecutive Vice President, Head of Research & Development and Chief Medical Officer at Elicio Therapeutics - View - Elicio Therapeutics org chart
Create your alert
to follow the career of Christopher Haqq.
Education
Christopher Haqq has a Bachelor of Science Biological Sciences from Stanford University.
They have also studied at Stanford University :
Find more alumni from Stanford University
More about Christopher Haqq
Selected links
Do you need to know more about Christopher Haqq? More results.
Participate
Social media
- Christopher Haqq on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Christopher Haqq
The colleagues of Christopher Haqq
Company Colleagues
- At Elicio Therapeutics, Christopher Haqq has 25 colleagues including Robert Connelly (CEO), Yekaterina Chudnovsky (Director)…
Industry Colleagues
- In the Biotechnology industry, Christopher Haqq has 35,753 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Christopher Haqq.
Get in Touch
Here are a few tips for establishing great contacts.
